The DOI matches its Crossref record; 45 of the 45 references it cites were found in a registry or an index.
Hostile takeovers: viral appropriation of the NF-kB pathway
Open accessAbstract
NF-κB in defense and diseaseTranscriptional regulators of the NF-κB/IκB family promote the expression of well over 100 target genes, the majority of which participate in the host immune response (1).These proteins include a multitude of cytokines and chemokines, receptors required for immune recognition, proteins involved in antigen presentation, and adhesion receptors involved in transmigration across blood vessels walls.Because of this extensive role in immune action, NF-κB has been termed the central mediator of the immune response.Gene knockout and other studies establish roles for NF-κB in the ontogeny of the immune system but also demonstrate that NF-κB participates at multiple steps during oncogenesis (2) and the regulation of programmed cell death (3).For several reasons, the NF-κB pathway provides an attractive target to viral pathogens.Activation of NF-κB is a rapid, immediate early (IE) event that occurs within minutes after exposure to a relevant inducer, does not require de novo protein synthesis, and results in a strong transcriptional stimulation of several early viral as well as cellular genes.In this review, we will describe strategies that viruses have evolved to modulate the NF-κB pathway, to enhance viral replication, host cell survival, and evasion of immune responses.Activation of NF-κB constitutes an obvious target because many of its target genes -growth factors, cytokines and their receptors, and protooncogenes -profoundly influence the host cell cycle.In addition, some viruses exploit the antiapoptotic properties of NF-κB to evade the host defense mechanisms that limit replication by killing infected cells, or conversely to trigger apoptosis as a mechanism to increase virus spread.Perhaps not surprisingly, the persistent activation of the NF-κB pathway maintained by certain viruses contributes to oncogenic transformation (2).In addition to the classic studies with the avian REV-T retrovirus which contains the v-Rel oncoprotein and induces a rapid and fatal B-cell lymphoma in young birds (4), several lines of evidence demonstrate that NF-κB family members contribute to human oncogenesis.Localization of NF-κB-encoding genes at sites of chromosomal translocations and genomic rearrangements in cancer, high levels of NF-κB activity in many breast cancer cells, and constitutive nuclear NF-κB complexes in Hodgkin's lymphoma cells all support this view (2).Furthermore, as discussed below, viral oncogene products, including human T-cell leukemia virus type 1 (HTLV-1) Tax protein and Epstein-Barr virus latent infection membrane protein 1 (EBV LMP1), each act by unique mechanisms to disrupt NF-κB regulation and initiate viral transformation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
NF-κB AND REL PROTEINS: Evolutionarily Conserved Mediators of Immune Responses
Ghosh, S., May, M. J., & Kopp, E. B. (1998) · Annual Review of Immunology · doi:10.1146/annurev.immunol.16.1.225 · Cited by 5,182
Activators and target genes of Rel/NF-κB transcription factors
Pahl, H. L. (1999) · Oncogene · doi:10.1038/sj.onc.1203239 · Cited by 3,727
Activators and Target Genes of Rel/NF-кB Transcription Factors: From Bench to Bedside
Loop, T., & Pahl, H. L. (2003) · Nuclear Factor кB · doi:10.1007/978-94-010-0163-2_1 · Cited by 3,169
NF-κB activation by tumour necrosis factor requires the Akt serine–threonine kinase
Nidai Ozes, O., Mayo, L. D., Gustin, J. A., Pfeffer, S. R., Pfeffer, L. M., & Donner, D. B. (1999) · Nature · doi:10.1038/43466 · Cited by 1,832
NF-κB is a target of AKT in anti-apoptotic PDGF signalling
Romashkova, J. A., & Makarov, S. S. (1999) · Nature · doi:10.1038/43474 · Cited by 1,517
Control of apoptosis by Rel/NF-κB transcription factors
Barkett, M., & Gilmore, T. D. (1999) · Oncogene · doi:10.1038/sj.onc.1203238 · Cited by 1,204
How NF-κB is activated: the role of the IκB kinase (IKK) complex
Karin, M. (1999) · Oncogene · doi:10.1038/sj.onc.1203219 · Cited by 1,156
Aberrant rel/nfkb genes and activity in human cancer
Rayet, B., & Gélinas, C. (1999) · Oncogene · doi:10.1038/sj.onc.1203221 · Cited by 1,110
Yamaoka, S., Courtois, G., Bessia, C., Whiteside, S. T., Weil, R., Agou, F., Kirk, H. E., Kay, R. J., & Israël, A. (1998) · Cell · doi:10.1016/s0092-8674(00)81466-x · Cited by 1,076
Roulston, A., Marcellus, R. C., & Branton, P. E. (1999) · Annual Review of Microbiology · doi:10.1146/annurev.micro.53.1.577 · Cited by 749
Zamanian-Daryoush, M., Mogensen, T. H., DiDonato, J. A., & Williams, B. R. G. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.4.1278-1290.2000 · Cited by 361
The ER-overload response: activation of NF-κB
Pahl, H. L., & Baeuerle, P. A. (1997) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(96)10073-6 · Cited by 332
Kinoshita, S., Su, L., Amano, M., Timmerman, L. A., Kaneshima, H., & Nolan, G. P. (1997) · Immunity · doi:10.1016/s1074-7613(00)80326-x · Cited by 318
Jeeninga, R. E., Hoogenkamp, M., Armand-Ugon, M., de Baar, M., Verhoef, K., & Berkhout, B. (2000) · Journal of Virology · doi:10.1128/jvi.74.8.3740-3751.2000 · Cited by 290
The Nef protein of HIV-1 associates with rafts and primes T cells for activation
Wang, J.-K., Kiyokawa, E., Verdin, E., & Trono, D. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.1.394 · Cited by 276
Harhaj, E. W., & Sun, S.-C. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.33.22911 · Cited by 232
Alcamí, J., Laín de Lera, T., Folgueira, L., Pedraza, M. A., Jacqué, J. M., Bachelerie, F., Noriega, A. R., Hay, R. T., Harrich, D., & Gaynor, R. B. (1995) · The EMBO Journal · doi:10.1002/j.1460-2075.1995.tb07141.x · Cited by 230
Role of Adapter Function in Oncoprotein-mediated Activation of NF-κB
Jin, D.-Y., Giordano, V., Kibler, K. V., Nakano, H., & Jeang, K.-T. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.25.17402 · Cited by 215
Multiple mutations contribute to the oncogenicity of the retroviral oncoprotein v-Rel
Gilmore, T. D. (1999) · Oncogene · doi:10.1038/sj.onc.1203222 · Cited by 200
Tai, D.-I., Tsai, S.-L., Chen, Y.-M., Chuang, Y.-L., Peng, C.-Y., Sheen, I.-S., Yeh, C.-T., Chang, K. S., Huang, S.-N., Kuo, G. C., et al. (2000) · Hepatology · doi:10.1002/hep.510310316 · Cited by 191
Sun, S.-C., & Ballard, D. W. (1999) · Oncogene · doi:10.1038/sj.onc.1203220 · Cited by 185
Chu, Z.-L., Shin, Y.-A., Yang, J.-M., DiDonato, J. A., & Ballard, D. W. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.22.15297 · Cited by 183
Roulston, A., Lin, R., Beauparlant, P., Wainberg, M. A., & Hiscott, J. B. (1995) · Microbiological Reviews · doi:10.1128/mr.59.3.481-505.1995 · Cited by 179
Self-citationPatel, A., Hanson, J., McLean, T. I., Olgiate, J., Hilton, M., Miller, W. E., & Bachenheimer, S. L. (1998) · Virology · doi:10.1006/viro.1998.9243 · Cited by 166
You, L.-R., Chen, C.-M., & Lee, Y.-H. W. (1999) · Journal of Virology · doi:10.1128/jvi.73.2.1672-1681.1999 · Cited by 160
McFarland, E. D. C., Izumi, K. M., & Mosialos, G. (1999) · Oncogene · doi:10.1038/sj.onc.1203217 · Cited by 159
Pise-Masison, C. A., Mahieux, R., Jiang, H., Ashcroft, M. A., Radonovich, M. F., Duvall, J. F., Guillerm, C., & Brady, J. N. (2000) · Molecular and Cellular Biology · doi:10.1128/.20.10.3377-3386.2000 · Cited by 158
Yurochko, A. D., Mayo, M. W., Poma, E., Baldwin, A. S., & Huang, E. (1997) · Journal of Virology · doi:10.1128/jvi.71.6.4638-4648.1997 · Cited by 147
Norris, J. L., & Baldwin, A. S. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.20.13841 · Cited by 147
Sylla, B. S., Hung, S. C., Davidson, D. M., Hatzivassiliou, E., Malinin, N. L., Wallach, D., Gilmore, T. D., Kieff, E., & Mosialos, G. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.17.10106 · Cited by 137
Weil, R., Sirma, H., Giannini, C., Kremsdorf, D., Chable-Bessia, C., Dargemont, C., Bréchot, C., & Israël, A. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.9.6345 · Cited by 136
Roux, P., Alfieri, C., Hrimech, M., Cohen, É. A., & Tanner, J. E. (2000) · Journal of Virology · doi:10.1128/jvi.74.10.4658-4665.2000 · Cited by 124
Harhaj, E. W., Good, L., Xiao, G., Uhlik, M. T., Cvijic, M. E., Rivera-Walsh, I., & Sun, S. (2000) · Oncogene · doi:10.1038/sj.onc.1203445 · Cited by 115
Chen, B. K., Feinberg, M. B., & Baltimore, D. (1997) · Journal of Virology · doi:10.1128/jvi.71.7.5495-5504.1997 · Cited by 106
Shao, R., Hu, M. C. ‐., Zhou, B. P., Lin, S., Chiao, P. J., von Lindern, R., Spohn, B., & Hung, M. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.31.21495 · Cited by 101
Kwon, H., Pelletier, N., DeLuca, C., Génin, P., Cisternas, S., Lin, R., Wainberg, M. A., & Hiscott, J. B. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.13.7431 · Cited by 94
Self-citationVerhoef, K., Sanders, R. W., Fontaine, V., Kitajima, S., & Berkhout, B. (1999) · Journal of Virology · doi:10.1128/jvi.73.2.1331-1340.1999 · Cited by 84
Montano, M. A., Nixon, C. P., & Essex, M. (1998) · Journal of Virology · doi:10.1128/jvi.72.10.8446-8452.1998 · Cited by 69
Flory, E., Weber, C. K., Chen, P., Hoffmeyer, A., Jassoy, C., & Rapp, U. R. (1998) · Journal of Virology · doi:10.1128/jvi.72.4.2788-2794.1998 · Cited by 55
Nuclear IκBβ Maintains Persistent NF-κB Activation in HIV-1-infected Myeloid Cells
DeLuca, C., Petropoulos, L., Zmeureanu, D., & Hiscott, J. B. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.19.13010 · Cited by 53
Self-citationManna, S. K., & Aggarwal, B. B. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.10.5156 · Cited by 53
Quinto, I., Mallardo, M., Baldassarre, F., Scala, G., Englund, G., & Jeang, K. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.25.17567 · Cited by 44
IκB-Mediated Inhibition of Virus-Induced Beta Interferon Transcription
Algarté-Génin, M., Nguyen, H., Heylbroeck, C., Lin, R., & Hiscott, J. B. (1999) · Journal of Virology · doi:10.1128/jvi.73.4.2694-2702.1999 · Cited by 39
Self-citationIκκ Mediates NF-κB Activation in Human Immunodeficiency Virus-Infected Cells
Asin, S., Taylor, J. A., Trushin, S., Bren, G. D., & Payá, C. V. (1999) · Journal of Virology · doi:10.1128/jvi.73.5.3893-3903.1999 · Cited by 36
Incomplete Regulation of NF-κB by IκBα during Respiratory Syncytial Virus Infection in A549 Cells
Fiedler, M. A., & Wernke-Dollries, K. (1999) · Journal of Virology · doi:10.1128/jvi.73.5.4502-4507.1999 · Cited by 23
Cited by
Control of oncogenesis and cancer therapy resistance by the transcription factor NF-κB
Baldwin, A. S. (2001) · Journal of Clinical Investigation · doi:10.1172/jci11991 · Cited by 1,434
Age and Age-Related Diseases: Role of Inflammation Triggers and Cytokines
Rea, I. M., Gibson, D. S., McGilligan, V., McNerlan, S. E., Alexander, H. D., & Ross, O. A. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00586 · Cited by 1,267
“The resulting hijacking of the NF-κB pathway, allows uncontrolled upregulation of cellular genes that govern growth-signal transduction, amplify the pro-inflammatory cytokines (IL-2, IL-6, IL-15, TNF), together with increasing expression of proto-oncogenes (c-Myc), and antiapoptotic proteins (bcl-xl) Hiscott Rayet (29…”
BackgroundNuclear factor-?B: its role in health and disease
Kumar, A., Takada, Y., Boriek, A., & Aggarwal, B. (2004) · Journal of Molecular Medicine · doi:10.1007/s00109-004-0555-y · Cited by 933
Zhang, G., & Ghosh, S. (2001) · Journal of Clinical Investigation · doi:10.1172/jci11837 · Cited by 777
To be, or not to be: NF-κB is the answer – role of Rel/NF-κB in the regulation of apoptosis
Kucharczak, J., Simmons, M. J., Fan, Y., & Gélinas, C. (2003) · Oncogene · doi:10.1038/sj.onc.1207230 · Cited by 769
Metadata
- Authors
- Hiscott, J., Kwon, H., & Génin, P.
- Venue
- Journal of Clinical Investigation
- Published
- 2001-01-15
- Volume
- 107
- Issue
- 2
- Pages
- 143-151
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W2129313145
- Cited by
- 613
- References
- 45
- FWCI
- 10.13
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.